However, as Phase 3 trials progress and regulatory submissions become more likely, it is important for patients and clinicians to be prepared for informed conversations about its use
Wegovy primarily focuses on the GLP-1 receptor, while Zepbound targets multiple receptors (GLP-1, GIP, and glucagon), which may offer additional benefits for appetite suppression and energy expenditure
Controlling the false discovery rate: a practical and powerful approach to multiple testing
Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancer
Your consultation includes a thorough review of your dental history, systemic health, medications, and goals
Characterization of the disulfides of bio-thiols by electrospray ionization and triple-quadrupole tandem mass spectrometry